Dermatan sulphate, heparin cofactor II, and F1+2 peptide in non-insulin- dependent diabetes mellitus

Thrombosis Research

Volumn 97, Issue 4, 2000, Pages 263-265

  Mascia, Fausto ^a   Paoletti, Patrizia ^a   Mameli, Giulia ^a   Mamusa, Angela Maria ^b   Cirillo, Rocco ^a   Marongiu, Francesco ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Territorial Department of Nephrology and Dialysis   (Italy)

Author keywords

Dermatan sulphate; F1+2 peptide; Heparin cofactor II; NIDDM

Indexed keywords

BLOOD CLOTTING FACTOR 10A; DERMATAN SULFATE; GLYCOSYLATED HEMOGLOBIN; HEPARIN COFACTOR II;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOLYSIS; HUMAN; HYPERCOAGULABILITY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; THROMBOSIS; VASCULAR ENDOTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DERMATAN SULFATE; DIABETES MELLITUS, TYPE 2; FEMALE; HEPARIN COFACTOR II; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTHROMBIN; RETROSPECTIVE STUDIES; VASCULAR DISEASES;

EID: 0033956187     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00167-X     Document Type: Article

References (14)

1. Barrett-Connor E., Wingard D.L. Sex differential heart mortality in diabetes. A prospective population based study Am J Epidemiol. 118:1988;489-496.
2. Jones R.L. Fibrinopeptide A in diabetes mellitus. Relation to levels of blood glucose, fibrinogen disappearance and hemodynamic changes. Diabetes. 34:1985;836-843.
3. Marongiu F., Conti M., Mameli G., Sorano G.G., Cossu E., Cirillo R., Balestrieri A. Is the imbalance between thrombin and plasmin activity in diabetes related to the behaviour of antiplasmin activity? Thromb Res. 58:1990;91-99.
4. Kannel W.B., D'Agostino R.B., Wilson P.W.F., Belanger A.J., Gannion D.R. Diabetes, fibrinogen and risk of cardiovascular disease. The Framingham experience Am Heart J. 120:1990;672-676.
5. Marongiu F., Mascia F., Mameli G., Cirillo R., Balestrieri A. Prothrombin fragment F1+2 levels are high in NIDDM independently of the Hb Alc. Thromb Haemost. 74:1995;805-806.
6. Lindhal U., Hook H. Glycosaminoglycanes and their binding to biological macromolecules. Ann Rev Biochem. 47:1978;385-417.
7. Tollefsen D.M., Pestka C.A., Monafo W.Y. Activation of heparin cofactor Il by dermatan sulphate. J Biol Chem. 258:1983;6713-6716.
8. Oohira A., Wight T.N., Bornstein P. Sulfated proteoglycans synthetized by vascular endothelial cells in culture. J Biol Chem. 258:1983;2014-2021.
9. Ceriello A., Quartaro A., Dello Russo P., Marchi E., Milani M.R., Giugliano D. Evidence for a reduced heparin cofactor Il biological activity in diabetes. Haemostasis. 20:1990;357-361.
10. Dubosq C., Quintana I., Barros J., Kordisch L. Heparin cofactor II in diabetic patients. Blood Coag Fibrinol. 5:1994;201-204.
11. Pelzer H., Schwarz A., Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 65:1991;153-159.
12. Dupouy D., Sié P., Dol F., Boneu B. A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma. Thromb Haemost. 60:1988;236-239.
13. Toleffsen D.M., Pestka C.A. Heparin cofactor II activity in patients with disseminated intravascular coagulation and hepatic failure. Blood. 66:1985;769-774.
14. Biondi G., Sorano G.G., Conti M., Cirillo R., Marongiu F. The behaviour of protein C in diabetes is still an open question. Thromb Haemost. 66:1991;267.